New Key Statistics Module, Z-Score and F-Score
NAS:BGLC Key Ratios
| Market Cap $ M | 10.47 |
| Enterprise Value $ M | 4.45 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.08 |
| Price/Sales | 0.94 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -0.18 |
| Beneish M-Score | -3.92 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.72 |
| EV-to-EBITDA | -1.79 |
| PEG | -- |
| Shares Outstanding M | 17.67 |
| Net Margin (%) | -26.91 |
| Operating Margin % | -26.55 |
| Pre-tax Margin (%) | -26.68 |
| Quick Ratio | 4.24 |
| Current Ratio | 4.93 |
| ROA % (ttm) | -27.56 |
| ROE % (ttm) | -34.11 |
| ROIC % (ttm) | -61.62 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.09 |
BGLC Number of Guru Trades
BGLC Volume of Guru Trades
Gurus Latest Trades with NAS:BGLC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BGLC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioNexus Gene Lab Corp Insider Transactions
No Available Data
News about NAS:BGLC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers